Non-Human Primate (NHP) Applications in IND-Enabling Translation

Q: How do you address the ethical and logistical challenges of using NHPs in research?

Creative Biolabs is committed to the highest ethical standards and fully embraces the principles of the 3Rs—reduce, refine, and replace. We employ advanced techniques like non-invasive monitoring and imaging to minimize stress and maximize the data obtained from each animal. Our robust supply chain and collaborative study designs ensure that NHP use is always scientifically justified and optimized.

Are you currently facing long drug development cycles, unpredictable preclinical outcomes, or challenges in securing regulatory approval? Creative Biolabs helps you accelerate drug discovery and streamline IND-enabling processes by providing high-quality, translatable data from our advanced NHP models. Through our extensive experience and innovative scientific platforms, we help de-risk your program, enabling a smoother transition to clinical trials.

Therapeutic Development & Translation with NHP Models

NHP models provide essential translational data for regulatory submissions and accurate risk assessment, offering unparalleled insight into a therapeutic candidate's safety and efficacy before first-in-human studies.

Get a Quote

Overview of NHP Applications

What Are Our Research Areas?

The journey from a promising therapeutic candidate to an approved drug is fraught with challenges. Preclinical research serves as the critical bridge, ensuring a molecule is safe and effective enough to be tested in humans. A cornerstone of this process is the strategic use of appropriate animal models. While other species play a role, NHPs are often uniquely positioned to provide the most relevant data for IND submissions, especially for complex biologics, gene therapies, and vaccines. Their close genetic and physiological similarities to humans make them an indispensable tool for mitigating clinical risk.

Safety Prediction & Dose Ranging: Determining a safe starting dose for a first-in-human trial is paramount. NHP models allow for robust toxicology studies that identify potential adverse effects and define a dose range for human clinical use. We provide critical data on a molecule's safety profile, helping you select the optimal dose and administration schedule to minimize risk in Phase I studies.
PK/PD Bridging & Human Dose Extrapolation: A key challenge in drug development is accurately predicting a molecule's behavior in humans based on animal data. NHPs are invaluable for establishing pharmacokinetic (PK) and pharmacodynamic (PD) correlations. Their similar metabolism and immunology allow for more reliable data, bridging the gap between preclinical findings and human responses. This goes far beyond simple allometric scaling, incorporating complex factors like species-specific target biology and clearance mechanisms to ensure your data is robust and translatable.

Why Choose Us?

NHPs offer a scientific advantage that is difficult to replicate with other preclinical models. This is particularly true for advanced therapies where complex biological interactions are critical.

Genetic and Immunological Similarities: NHPs share a high degree of genetic homology with humans. This allows for more accurate predictions of how a drug will interact with its intended target and how the immune system will respond, helping to avoid issues like unexpected immunogenicity or cytokine storms.
Clinical Translational Relevance: NHP models are often the only non-clinical species that can recapitulate complex human diseases, making them ideal for assessing a drug's efficacy and translational potential. This enables more reliable early proof of concept.
Data Types Required for Regulatory Submissions: Regulatory bodies often require data from a relevant non-rodent species, and NHPs are frequently the model of choice for biologics and gene therapies. NHP biodistribution data, for instance, is a critical component of many AAV gene therapy IND submissions.

Key Applications

Creative Biolabs' NHP models are applied to a wide range of therapeutic areas, providing essential data for IND submissions.

Gene Therapy: NHPs are the gold standard for evaluating viral vector biodistribution and shedding studies. Their larger body size allows for systemic administration and the collection of extensive, longitudinal data on vector location, dose, and clearance.
Oncology & Immunotherapy: The complexity of the tumor microenvironment and immune checkpoint pathways requires a highly translational model. NHPs are used for modeling cytokine release syndrome for therapies like CAR-T, as well as for evaluating the efficacy of immune checkpoint inhibitors (ICIs) and other novel biologics.
Central Nervous System (CNS) & Neurological Disorders: Due to their cognitive and anatomical similarities to humans, NHPs are essential for modeling complex neurological disorders. They are used to study disease progression and evaluate the efficacy of therapeutics for diseases like Parkinson's and Alzheimer's.
Vaccines & Infectious Diseases: NHPs have played a pivotal role in the development of life-saving vaccines, including those for polio, HIV, and COVID-19. They are used in challenge and protection studies to evaluate a vaccine's ability to elicit a protective immune response.

How Do Creative Biolabs Support Your Projects?

Instead of a rigid experimental process, Creative Biolabs provides a flexible suite of services that can be tailored to your specific program needs. Our scientific team works with you to design a study that maximizes data value and accelerates your timeline.

Service Capability	Corresponding Application Area
In Vitro DMPK Assays	Understanding a drug's absorption, distribution, metabolism, and excretion in a controlled environment.
In Vivo Toxicology Studies	Evaluating a therapeutic candidate's safety profile and identifying potential adverse effects.
In Vitro Cell-Based Safety Assays	Screening for early signs of toxicity and immune-mediated adverse events.
PK/TK Sample Analysis	Precisely measuring drug levels and vector presence in biological samples.

Translational Impact

By leveraging Creative Biolabs' NHP models, you gain a significant advantage in your drug development program. Our approach leads to more reliable early proof of concept, enabling early detection of potential immune responses or toxicity that could derail a clinical trial. This reduced risk of IND failure translates directly to cost and time savings. NHP biodistribution data, for example, is often a requirement from the regulatory agencies for gene therapy IND submissions, providing a critical piece of the regulatory puzzle. Our data is meticulously collected, providing a seamless path for regulatory review.

Frequently Asked Questions

Q: What is the resolution or sensitivity of your assays in NHP models?

A: Our bioanalytical platforms, including LC-MS/MS and advanced ligand-binding assays, are highly sensitive and validated to meet stringent regulatory requirements. We can detect and quantify your therapeutic at low concentrations and provide high-resolution biomarker data. Our team works with you to optimize assay conditions for your specific molecule.

Q: What is the cell source and sample stability for your in vitro assays?

A: We utilize a variety of primary NHP cells and tissues from our own biobank. All samples are ethically sourced and meticulously managed under strict protocols. We have extensive experience with different cell types and can provide data on sample stability to ensure the integrity of your results.

Q: How do you address the ethical and logistical challenges of using NHPs in research?

A: Creative Biolabs is committed to the highest ethical standards and fully embraces the principles of the 3Rs—reduce, refine, and replace. We employ advanced techniques like non-invasive monitoring and imaging to minimize stress and maximize the data obtained from each animal. Our robust supply chain and collaborative study designs ensure that NHP use is always scientifically justified and optimized.

Q: How do NHP models compare to alternative methods like humanized mice or in vitro systems?

A: Humanized mice can provide targeted insights, but they lack the physiological and anatomical similarities needed for a full translational picture. We believe the future of biomedical research lies in an integrated approach that leverages the strengths the irreplaceable value of NHP models.

Contact Us

Our team of expert scientists is ready to partner with you to accelerate your drug development journey. We can help you design a preclinical program that provides the clear, translatable data you need for a successful IND submission. Contact Creative Biolabs, which is your partner in IND-enabling translation, providing the preclinical confidence needed to bring your innovative therapies to patients.